Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile-Associated Diarrhea (CDAD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Large-scale testing (Phase 3)Study completedNCT02179658
What this trial is testing

Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile
Astellas Pharma Inc 210
Large-scale testing (Phase 3)Study completedNCT00468728
What this trial is testing

PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 535
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Testing effectiveness (Phase 2)Study completedNCT04247542
What this trial is testing

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Acurx Pharmaceuticals Inc. 53
Large-scale testing (Phase 3)Study completedNCT01691248
What this trial is testing

Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)

Who this might be right for
Clostridium Difficile-Associated Diarrhea (CDAD)
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 611
Testing effectiveness (Phase 2)Study completedNCT01559545
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of Two Formulations of Metronidazole Versus Immediate Release Metronidazole in Patient With C. Difficile Colitis

Who this might be right for
Clostridium Difficile Associated Diarrhea
Dr. Reddy's Laboratories Limited 60
Large-scale testing (Phase 3)Ended earlyNCT01143272
What this trial is testing

Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea

Who this might be right for
Antibiotic-associated DiarrheaClostridium DifficileDiarrhea
Bernhard Nocht Institute for Tropical Medicine 477
Large-scale testing (Phase 3)Study completedNCT00269399
What this trial is testing

A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Bausch Health Americas, Inc. 237
Early research (Phase 1)Study completedNCT02835105
What this trial is testing

Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 40
Not applicableUnknownNCT03141775
What this trial is testing

Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)

Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Diarrhea
University of Cologne 541
Large-scale testing (Phase 3)Study completedNCT01983683
What this trial is testing

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium Difficile Infection
Actelion 631
Testing effectiveness (Phase 2)Study completedNCT00034294
What this trial is testing

GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Clostridium Difficile-Associated DiarrheaClostridium EnterocolitisClostridium Difficile Diarrhea+2 more
Genzyme, a Sanofi Company 300
Post-approval studies (Phase 4)Ended earlyNCT04003818
What this trial is testing

Efficacy and Safety of Teicoplanin in CDAD

Who this might be right for
Clostridium Difficile Infection-associated Diarrhea and Colitis
Sanofi 50
Large-scale testing (Phase 3)Study completedNCT00314951
What this trial is testing

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Large-scale testing (Phase 3)Study completedNCT00196794
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisDiarrhea
Genzyme, a Sanofi Company 520
Early research (Phase 1)Study completedNCT02835118
What this trial is testing

Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Study completedNCT01591863
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile-associated Diarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 38
Testing effectiveness (Phase 2)Study completedNCT03824795
What this trial is testing

Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD

Who this might be right for
Clostridium Difficile Infection
MGB Biopharma Limited 34